However, you cannot simply swap one for another
Important safety considerations include: Gastrointestinal symptoms at higher doses Individual tolerance variability Potential for hypoglycaemia when combined with insulin or sulphonylureas Limited long-term safety data in humans Limited data in children and adolescents Patients with diabetes taking glucose-lowering medications should exercise caution when introducing allulose
With Eli Lilly running 2,200-patient Phase 3 addiction trials and JAMA Psychiatry publishing positive semaglutide results for AUD, psychiatrists who treat reinforcement dysregulation need to understand this drug class now
Binding to the GLP-1 receptor (GLP-1R), a G protein-coupled receptor (GPCR) widely expressed throughout the body, GLP-1 enhances glucose-dependent insulin secretion and suppresses glucagon, thereby supporting stable glycemia
Its making the lifestyle changes more achievable
But when the medication is discontinued, those effects gradually wear off